3,4-methylenedioxymethamphetamine/Finding
One finding, on its own
A single claim from the graph, with the evidence strength computed from its study, the sentence it was drawn from, and the paper. This address does not change.
Increases diastolic blood pressure (setting unspecified)
ModerateEvidence strength: moderate. Human evidence with one recorded weakness, or capped at moderate by its design or by unread numbers.Finding“The MDMA group higher SBP and DBP compared to the placebo group.”
Quoted verbatim from A randomized controlled trial of 3,4-methylenedioxymethamphetamine (MDMA) and fear extinction retention in healthy adults.. - Study
- RCT
- Dose
- 100 mg single oral dose
- Population
- Healthy adults aged 21-55 with prior recreational MDMA use, single 100 mg oral dose versus matching placebo in a parallel-group trial; blood pressure monitored at eight timepoints over the 6 hours after dosing
A randomized controlled trial of 3,4-methylenedioxymethamphetamine (MDMA) and fear extinction retention in healthy adults.2022PMID:35166140Industry fundedPermalink
Keep reading
- Everything the graph holds on 3,4-methylenedioxymethamphetamine
- Every compound studied against Diastolic blood pressure (setting unspecified)
- How to read the evidence strength and the marks
To cite this finding: https://catalystproject.ai/e/01M45WWKZE073NJ60PP0D6XYDW